Soc. Generale Call 42.76 OMV 20.0.../ DE000SU13UX8 /
2024-07-31 4:47:57 PM | Chg.+0.030 | Bid4:58:28 PM | Ask4:58:28 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.260EUR | +13.04% | 0.250 Bid Size: 30,000 |
0.260 Ask Size: 30,000 |
OMV AG | 42.76 EUR | 2025-06-20 | Call |
GlobeNewswire
03-26
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
01-16
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
2023-09-14
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
euro adhoc
2021-10-13
EANS-Adhoc: OMV Aktiengesellschaft / OMV announces redemption of the NC6 Hybrid Notes 2015 EAE
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
2018-12-04
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center